
Kivoflam D by Kivonyx Healthcare Pvt. Ltd. is a combination pharmaceutical formulation containing Trypsin, Bromelain, Rutoside Trihydrate, and Diclofenac Sodium. Available in 10 × 10 tablet packaging, Kivoflam D is prescribed for managing pain, inflammation, and swelling associated with musculoskeletal conditions, soft tissue injuries, and postoperative recovery. Diclofenac Sodium provides analgesic and anti-inflammatory effects, while Trypsin and Bromelain are proteolytic enzymes used to support the management of inflammatory swelling. Rutoside Trihydrate provides antioxidant properties. Kivoflam D Tablets should be taken only under medical supervision because of potential side effects and contraindications. Kivonyx Healthcare Pvt. Ltd. offers this product in its pharmaceutical range. For bulk supply, distribution, and PCD pharma franchise enquiries, contact the company.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.